Thiazolidinediones: an update
- PMID: 10768450
- DOI: 10.1016/S0140-6736(00)90002-3
Thiazolidinediones: an update
Abstract
Thiazolidinediones, which are being developed for the treatment of insulin resistance and type 2 diabetes mellitus, bind and activate peroxisome proliferator-activated receptor gamma, a nuclear receptor that regulates the expression of several genes involved in metabolism. This receptor controls adipocyte differentation, lipid storage, and insulin sensitisation. Besides metabolic activities, thiazolidinediones have effects as diverse as the control of host defence, cell proliferation, and tumorigenesis.
Comment in
-
Information on thiazolidinediones.Lancet. 2000 Jul 15;356(9225):254-5. doi: 10.1016/S0140-6736(05)74507-4. Lancet. 2000. PMID: 10963229 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
